Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPFZ.L Regulatory News (PFZ)

  • There is currently no data for PFZ

Form 38.5a

4 Nov 2015 13:16

RNS Number : 5546E
GoldmanSachs International
04 November 2015
 

Ap24

 

FORM 38.5(a)

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5(a) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISEDINTERMEDIARY STATUS AND DEALING IN A CLIENT-SERVING CAPACITY

 

1. KEY INFORMATION

 

Name of exempt principal trader

(GS) GOLDMAN SACHS INTERNATIONAL

Company dealt in

PFIZER INC

Class of relevant security to which the dealings being disclosed relate (Note 1)

USD Ordinary

Date of dealing

03 November 2015

 

2. DEALINGS (Note 2)

 

(a) Purchases and sales

 

Total number of relevant securities acquired

Highest price paid (Note 3)

Lowest price paid

(Note 3)

1,413

34.9350 USD

34.9142 USD

 

Total number of securities disposed

Highest price received (Note 3)

Lowest price received

(Note 3)

1,413

35.0000 USD

34.8300 USD

 

(b) Derivatives transactions (other than options transactions)

 

Product name,

e.g. CFD

Nature of transaction

(Note 4)

Number of relevant securities

(Note 5)

Price per unit

(Note 3)

 

Ap25

 

(c) Options transactions in respect of existing relevant securities

 

 

(i) Writing, selling, purchasing or varying

 

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 5)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 3)

Call Option / (1.00 : 100.00)

Exercising

58 (5,800)

32.0000 USD

AMERICAN

20/11/2015

0.0000 USD

Call Option / (1.00 : 100.00)

Exercising

56 (5,600)

33.0000 USD

AMERICAN

20/11/2015

0.0000 USD

Put Option / (1.00 : 100.00)

Selling

19 (1,900)

32.0000 USD

AMERICAN

20/11/2015

0.1100 USD

Put Option / (1.00 : 100.00)

Selling

31 (3,100)

32.0000 USD

AMERICAN

20/11/2015

0.1100 USD

Put Option / (1.00 : 100.00)

Selling

8 (800)

32.0000 USD

AMERICAN

20/11/2015

0.1100 USD

Put Option / (1.00 : 100.00)

Selling

56 (5,600)

33.0000 USD

AMERICAN

20/11/2015

0.2200 USD

Put Option / (1.00 : 100.00)

Selling

13 (1,300)

34.0000 USD

AMERICAN

18/12/2015

0.9400 USD

 

(ii) Exercising

 

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 3)

 

3.  OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities underany option referred to on this form or relating to the voting rights or future acquisition or disposalof any relevant securities to which any derivative referred to on this form is referenced.If none, this should be stated.

 

 

 

 

 

 

Date of disclosure

04 November 2015

Contact name

Aadithya Rao and Yiannis Bardis

Telephone number

+44(20) 7051 9046 / +44(20) 7774 7107

Name of offeree/offeror with which connected

Pfizer Inc

Nature of connection (Note 6)

Advisor to Offeror

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ISEEADFLEFASFFF
Date   Source Headline
20th Nov 201510:36 amRNSRule 38.5 - Pfizer INC
20th Nov 201510:34 amRNSRule 38.5 - Pfizer INC
19th Nov 20153:32 pmRNSForm 8.3 - Pfizer Inc
19th Nov 20153:24 pmRNSForm 8.3 - Allergan plc
19th Nov 20153:13 pmRNSForm 8.3 - [PFIZER INC]
19th Nov 20153:10 pmRNSForm 8.3 - Pfizer Inc.
19th Nov 20153:10 pmRNSForm 8.3 - Pfizer, Inc.
19th Nov 20153:09 pmBUSForm 8.3 - Pfizer Inc.
19th Nov 20153:06 pmRNSForm 8.3 - Pfizer Inc
19th Nov 20153:01 pmRNSForm 8.3 - Pfizer Inc Amendment
19th Nov 20152:35 pmRNSForm 8.3 - PFIZER INC
19th Nov 20152:34 pmRNSForm 8.3 - ALLERGAN PLC
19th Nov 20152:33 pmRNSForm 8.3 - Pfizer Inc
19th Nov 20152:22 pmRNSForm 8.3 - Allergan Plc
19th Nov 20152:03 pmRNSForm 38.5b
19th Nov 20152:00 pmRNSForm 38.5b
19th Nov 20151:59 pmRNSForm 38.5a
19th Nov 20151:52 pmRNSForm 8.1 - [Pfizer Inc.]
19th Nov 201512:34 pmRNSForm 8.3 - Allergan plc
19th Nov 201511:55 amRNSForm 8.3 - Pfizer, Inc.
19th Nov 201511:48 amRNSForm 38.5(b) - Pfizer Inc
19th Nov 201510:52 amRNSRule 38.5 - Pfizer INC
19th Nov 201510:50 amRNSRule 38.5 - Pfizer INC
19th Nov 201510:49 amRNSRule 38.5 - Pfizer INC
18th Nov 20153:26 pmRNSForm 8.3 - Pfizer Inc Amendment
18th Nov 20153:18 pmRNSForm 8.3 - ALLERGAN PLC
18th Nov 20153:17 pmRNSForm 8.3 - [PFIZER INC]
18th Nov 20153:16 pmRNSForm 8.3 - Pfizer Inc
18th Nov 20153:14 pmRNSForm 8.3 - Pfizer Inc.
18th Nov 20153:02 pmRNSRule 38.5 - Replacement Pfizer INC
18th Nov 20152:59 pmRNSForm 8.3 - Allergan plc
18th Nov 20152:58 pmRNSForm 8.3 - Pfizer, Inc.
18th Nov 20152:55 pmRNSForm 8.3 - PFIZER INC
18th Nov 20152:55 pmRNSForm 8.3 - Allergan plc
18th Nov 20152:51 pmRNSForm 8.3 - Pfizer Inc
18th Nov 20152:49 pmRNSForm 8.3 - Pfizer Inc
18th Nov 20152:41 pmRNSForm 8.3 - Allergan Plc
18th Nov 20152:14 pmBUSForm 8.3 - Pfizer Inc.
18th Nov 201511:55 amRNSForm 8.3 - Pfizer Inc.
18th Nov 201511:39 amRNSForm 38.5(b) - Pfizer Inc
18th Nov 201511:34 amRNSForm 8.1a - Pfizer Inc
18th Nov 201511:27 amRNSForm 8.1 - [Pfizer]
18th Nov 201511:25 amRNSForm 38.5b
18th Nov 201511:23 amRNSForm 38.5a
18th Nov 201511:23 amRNSForm 38.5b
18th Nov 201510:30 amRNSRule 38.5 - Pfizer INC
18th Nov 201510:28 amRNSRule 38.5 - Pfizer INC
18th Nov 201510:26 amRNSRule 38.5 - Pfizer INC
17th Nov 20153:53 pmRNSForm 8.3 - Pfizer Inc Amendment
17th Nov 20153:36 pmRNSForm 8.3 - Pfizer, Inc.

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.